|
公司基本資料信息
|
H-1501 | Head activator | C54H84N12O14 | 1125.33 | 79943-68-3 | Pyr-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe-OH |
H-1502 | Head activator (7-11) | C32H54N6O6 | 618.82 | 103404-59-7 | H-Lys-Val-Ile-Leu-Phe-OH Acetate salt? |
H-1503 | Pedibin Precursor (hydra) | C228H369N61O86S | 5372.86 | ? | H-Met-Glu-Ser-Glu-His-Glu-Val-Ser-Thr-Pro-Val-Ser-Ala-Glu-Glu-Leu-Lys-Ala-Glu-Ile-Ala-Val-Leu-Gln-Glu-Lys-Leu-Ala-Ala-Gly-Glu-Asp-Val-Ser-His-Glu-Leu-Glu-Glu-Lys-Glu-Lys-Ala-Leu-Ala-Asn-His-Ser-Glu-OH |
H-1601 | Hydrin 1, (Arg8,Gly10,Lys11,Arg12)-Vasotocin | C57H93N21O16S2 | 1392.63 | 122842-47-1 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-Arg-OH (Disulfide bond)? |
H-1602 | Hydrin 1', (Arg8,Gly10,Lys11)-Vasotocin | C51H81N17O15S2 | 1236.44 | 148440-73-7 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-OH (Disulfide bond)? |
H-1603 | Hydrin 2 (Arg8,Gly10)-Vasotocin |
C45H69N15O14S2? | 1108.27 | 122842-55-1 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-OH (Disulfide bond) |
H-1701 | Hylambatin | C63H90N16O19S2 | 1439.64 | 80890-46-6 | H-Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
H-1702 | Entero-Hylambatin | C63H91N17O18S2 | 1438.65 | 198541-90-1 | H-Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
I-0101 | ? | C23H32N5O12P | 601.51 | 290810-63-8 | H-Asn-Pro-Glu-Tyr(PO3H2)-OH |
I-0102 | IGF-I Analog | C55H88N14O15S2 | 1249.52 | 147819-32-7 | H-Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys-OH (Disulfide bond)? |